Stock Analysis

Here's What Analysts Are Forecasting For Revenio Group Oyj (HEL:REG1V) After Its Annual Results

HLSE:REG1V
Source: Shutterstock

Revenio Group Oyj (HEL:REG1V) shareholders are probably feeling a little disappointed, since its shares fell 6.9% to €28.02 in the week after its latest yearly results. Revenues of €104m were in line with forecasts, although statutory earnings per share (EPS) came in below expectations at €0.69, missing estimates by 2.9%. This is an important time for investors, as they can track a company's performance in its report, look at what experts are forecasting for next year, and see if there has been any change to expectations for the business. So we gathered the latest post-earnings forecasts to see what estimates suggest is in store for next year.

View our latest analysis for Revenio Group Oyj

earnings-and-revenue-growth
HLSE:REG1V Earnings and Revenue Growth February 16th 2025

Taking into account the latest results, the current consensus from Revenio Group Oyj's five analysts is for revenues of €116.9m in 2025. This would reflect a solid 13% increase on its revenue over the past 12 months. Per-share earnings are expected to bounce 31% to €0.91. Before this earnings report, the analysts had been forecasting revenues of €118.2m and earnings per share (EPS) of €0.96 in 2025. The analysts seem to have become a little more negative on the business after the latest results, given the small dip in their earnings per share numbers for next year.

The consensus price target held steady at €31.88, with the analysts seemingly voting that their lower forecast earnings are not expected to lead to a lower stock price in the foreseeable future. That's not the only conclusion we can draw from this data however, as some investors also like to consider the spread in estimates when evaluating analyst price targets. The most optimistic Revenio Group Oyj analyst has a price target of €33.50 per share, while the most pessimistic values it at €30.00. The narrow spread of estimates could suggest that the business' future is relatively easy to value, or thatthe analysts have a strong view on its prospects.

One way to get more context on these forecasts is to look at how they compare to both past performance, and how other companies in the same industry are performing. We can infer from the latest estimates that forecasts expect a continuation of Revenio Group Oyj'shistorical trends, as the 13% annualised revenue growth to the end of 2025 is roughly in line with the 14% annual growth over the past five years. By contrast, our data suggests that other companies (with analyst coverage) in a similar industry are forecast to see their revenues grow 16% per year. So it's pretty clear that Revenio Group Oyj is expected to grow slower than similar companies in the same industry.

The Bottom Line

The most important thing to take away is that the analysts downgraded their earnings per share estimates, showing that there has been a clear decline in sentiment following these results. On the plus side, there were no major changes to revenue estimates; although forecasts imply they will perform worse than the wider industry. The consensus price target held steady at €31.88, with the latest estimates not enough to have an impact on their price targets.

With that in mind, we wouldn't be too quick to come to a conclusion on Revenio Group Oyj. Long-term earnings power is much more important than next year's profits. We have forecasts for Revenio Group Oyj going out to 2027, and you can see them free on our platform here.

We also provide an overview of the Revenio Group Oyj Board and CEO remuneration and length of tenure at the company, and whether insiders have been buying the stock, here.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About HLSE:REG1V

Revenio Group Oyj

Provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, rest of Europe, North America, and internationally.

Flawless balance sheet with reasonable growth potential.